课题基金基金详情
Ttc36抑制线粒体依赖的凋亡途径促进急性肾损伤修复的作用和分子机制研究
结题报告
批准号:
81873932
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
周钦
依托单位:
学科分类:
H1701.创伤
结题年份:
2022
批准年份:
2018
项目状态:
已结题
项目参与者:
谢亚均、李千音、刘娅敏、何庆龄、陈蕾、吴亚飞、刘佳宁、倪东升、辜玉萍
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
急性肾损伤(AKI)是一类临床常见的危重疾病,进展快,死亡率高。肾近曲小管细胞的线粒体凋亡途径与AKI修复密切相关,分子机制尚不清。基于我们自科项目(81572076)支持构建的Ttc36敲除小鼠,建立AKI小鼠模型,发现Ttc36敲除后的肾损伤程度与野生型相比明显加重;且TTC36表达量与AKI修复程度呈负相关。细胞水平,TTC36能抑制肾近曲小管细胞的凋亡,影响线粒体分布和形态。本项目研究TTC36在AKI修复中的作用和分子机制。基于Ttc36基因敲除小鼠,拟分别构建体内、外AKI模型,通过干预TTC36,检测其对肾形态和功能,肾近曲小管细胞凋亡及线粒体功能的影响;深入探寻TTC36是否通过调控线粒体影响肾近曲小管细胞凋亡过程。综上,阐明TTC36在AKI修复中的具体分子机制,提供研发TTC36小分子治疗药物的依据,建立AKI修复评估的新指标,拓展AKI早期干预治疗的新思路。
英文摘要
Acute kidney injury (AKI) is a common clinical critically disease with rapid progression and high mortality. The apoptosis of renal proximal tubule cells and mitochondrial function are both closely related to the progress and repair of AKI. However, the molecular mechanisms remain largely unknown. With the support of our Natural Science Foundation of China (81572076), we successfully established Ttc36 homozygous knockout mice. We further constructed AKI mouse model, and found that Ttc36-/- mice showed increasingly degree of damage compared to the wild type. Moreover,the expression of TTC36 was negatively correlated with the repair level of AKI. At the cellular level, overexpression of TTC36 could inhibit proximal tubule cell apoptosis and disrupt mitochondrial distribution and morphology. Based on the above results, we intend to investigate functions and molecular mechanisms of TTC36 in AKI repair process. In this study, we propose to assess the alteration of renal morphology and function, renal proximal tubule cells apoptosis as well as mitochondrial features by intervening TTC36 in AKI model. Furthermore, we will explore in depth about the mechanism of TTC36 in AKI repair process which is dependent on mitochondrial-mediated apoptosis of renal proximal tubule cells. Ultimately, our work will clarify the molecular mechanism of TTC36 in AKI,and provide a potential marker for AKI repair appraisal. More importantly, the available of preparing TTC36 chemical analogue due to low molecular weight sheds the light on a new solution for AKI therapy.
肾脏疾病严重危害人类健康,影响患者生活质量,而肾小管上皮细胞损伤是导致急慢性肾脏疾病发生发展的关键因素之一,深入探究其潜在的分子机制对于肾脏疾病的诊疗具有重要意义。本研究证明小分子TTC36在急性肾损伤中,参与调控近曲小管上皮细胞的线粒体功能,与肾损伤程度呈负相关;在慢性肾脏疾病中,TTC36通过TGF-β信号影响近曲小管上皮细胞上皮间质转化,参与了肾脏纤维化的调控。我们的研究进一步丰富了TTC36在肾脏疾病中的作用,并探究了肾脏疾病发生发展新的调控机制,为肾脏疾病的诊疗提供了潜在新指标。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.gene.2022.146559
发表时间:2022-05
期刊:Gene
影响因子:3.5
作者:Huajie Mao;Ya Zhao;Li Lei;Yanxia Hu;Ha Zhu;Runzhi Wang;Dongsheng Ni;Jianing Liu;Lei Xu
通讯作者:Huajie Mao;Ya Zhao;Li Lei;Yanxia Hu;Ha Zhu;Runzhi Wang;Dongsheng Ni;Jianing Liu;Lei Xu
Laser-induced graphene (LIG)-based Au@CuO/V2CTx MXene non-enzymatic electrochemical sensors for the urine glucose test
用于尿糖测试的基于激光诱导石墨烯 (LIG) 的 Au@CuO/V2CTx MXene 非酶电化学传感器
DOI:10.1016/j.cej.2023.141303
发表时间:2023-01-09
期刊:CHEMICAL ENGINEERING JOURNAL
影响因子:15.1
作者:Cui, Feiyun;Sun, Haiming;Zhou, Qin
通讯作者:Zhou, Qin
HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage
TTC36-STK33-PELI1 信号轴调节的 HPD 降解可诱导酪氨酸血症和神经损伤
DOI:10.1038/s41467-019-12011-0
发表时间:2019-09-19
期刊:NATURE COMMUNICATIONS
影响因子:16.6
作者:Xie, Yajun;Lv, Xiaoyan;Zhou, Qin
通讯作者:Zhou, Qin
PPP3CB Inhibits Migration of G401 Cells via Regulating Epithelial-to-Mesenchymal Transition and Promotes G401 Cells Growth
PPP3CB 通过调节上皮间质转化抑制 G401 细胞迁移并促进 G401 细胞生长
DOI:10.3390/ijms20020275
发表时间:2019-01-02
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子:5.6
作者:Chen, Lei;He, Qingling;Li, Qianyin
通讯作者:Li, Qianyin
HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma.
HPGDS 是一种与肺腺癌脂质代谢和侵袭性相关的新型预后标志物
DOI:10.3389/fonc.2022.894485
发表时间:2022
期刊:FRONTIERS IN ONCOLOGY
影响因子:4.7
作者:Shao, Fengling;Mao, Huajie;Luo, Tengling;Li, Qijun;Xu, Lei;Xie, Yajun
通讯作者:Xie, Yajun
基于PEAK1对细胞骨架蛋白调控肥胖相关疾病的作用和分子机制及其监测方法研究
  • 批准号:
    --
  • 项目类别:
    重点项目
  • 资助金额:
    297万元
  • 批准年份:
    2020
  • 负责人:
    周钦
  • 依托单位:
基于TALEN技术敲除的ttc36小鼠研究高酪氨酸血症关键代谢酶HPD的分子调控机制
  • 批准号:
    81572076
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2015
  • 负责人:
    周钦
  • 依托单位:
国内基金
海外基金